AtriCure shareholders approve share increases for 2023 Stock Incentive Plan and 2018 ESPP

AtriCure, Inc.

Shareholders approved amendment to 2023 Stock Incentive Plan, increasing authorized shares from 4.5M to 6M.
Shareholders approved amendment to 2018 Employee Stock Purchase Plan, increasing authorized shares by 750,000.
All nine director nominees elected; Deloitte ratified as auditor; say-on-pay approved with over 40M votes.
Stock plan amendment passed with ~41M for vs 1.1M against; broker non-votes of 3.8M.

item 5.02item 5.07item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.